Aristides Capital LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 22 filers reported holding TRINITY BIOTECH PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Aristides Capital LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2023$119,319
-22.7%
162,3170.0%0.05%
-17.5%
Q2 2023$154,380
+1.2%
162,3170.0%0.06%
-22.2%
Q1 2023$152,578
-29.8%
162,317
-26.1%
0.08%
-26.4%
Q4 2022$217,335
-12.4%
219,530
-5.2%
0.11%
-41.2%
Q3 2022$248,000
-15.9%
231,509
-3.8%
0.19%
-7.4%
Q2 2022$295,000240,6790.20%
Other shareholders
TRINITY BIOTECH PLC shareholders Q2 2022
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders